You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 282 No. 21, December 1, 1999 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Special Communication
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (53)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Lipids and Lipid Disorders
 •Alert me on articles by topic

Preventing Coronary Artery Disease by Lowering Cholesterol Levels

Fifty Years From Bench to Bedside

Daniel Steinberg, MD, PhD; Antonio M. Gotto, Jr, MD, DPhil

JAMA. 1999;282:2043-2050.

In the more than 50 years since the founding of the National Heart, Lung, and Blood Institute and the American Heart Association, medical science has moved from an era in which hypercholesterolemia, as it is now defined, was not believed to be abnormal to one in which controlling hypercholesterolemia is known to reduce not only coronary artery disease morbidity and mortality but also total mortality. While the efforts and successes of many researchers involved in this evolution are impressive, atherosclerosis is still a major cause of death and disability in many developed nations, mostly in the form of myocardial infarction and stroke, and is an increasing cause of morbidity and mortality in developing nations. Many questions about the detailed pathogenesis of the disease remain. Elucidating the roles of high-density lipoprotein, other lipoproteins, and homocysteine, as well as the roles of cytokines and growth factors, will permit better understanding and treatment of atherosclerosis. With continuing support for research and encouragement of physicians and patients to follow recommended preventive regimens, further progress can be made against this major cause of death.


Author Affiliations: Departments of Medicine, University of California, San Diego (Dr Steinberg), and Weill Medical College of Cornell University, New York, NY (Dr Gotto).


RELATED ARTICLE

December 1, 1999
JAMA. 1999;282(21):2087-2088.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Rabbits fed cholesterol-enriched diets exhibit pathological features of inclusion body myositis
Chen et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008;294:R829-R835.
ABSTRACT | FULL TEXT  

Pathobiological Determinants of Atherosclerosis in Youth Risk Scores Are Associated With Early and Advanced Atherosclerosis
McMahan et al.
Pediatrics 2006;118:1447-1455.
ABSTRACT | FULL TEXT  

Pretreatment with Simvastatin Reduces Lung Injury Related to Intestinal Ischemia-Reperfusion in Rats
Pirat et al.
Anesth. Analg. 2006;102:225-232.
ABSTRACT | FULL TEXT  

The IDEAL Cholesterol: Lower Is Better
Cannon
JAMA 2005;294:2492-2494.
FULL TEXT  

Starting Earlier to Prevent Heart Disease
McGill and McMahan
JAMA 2003;290:2320-2322.
FULL TEXT  

Fractional Esterification Rate of Cholesterol and Ratio of Triglycerides to HDL-Cholesterol Are Powerful Predictors of Positive Findings on Coronary Angiography
Frohlich and Dobiasova
Clin. Chem. 2003;49:1873-1880.
ABSTRACT | FULL TEXT  

Seminal Changes in the Management of the Acute Coronary Event: Current Concepts
Futterman and Lemberg
Am J Crit Care 2003;12:73-76.
FULL TEXT  

Behavioral Medicine in the Prevention and Treatment of Cardiovascular Disease
Graves and Miller
Behav Modif 2003;27:3-25.
ABSTRACT  

Use of Statins and Aspirin to Reduce Risks of Cardiovascular Disease
Hebert et al.
J CARDIOVASC PHARMACOL THER 2002;7:77-80.
 

Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy: An Invited Review
Gorelick
Stroke 2002;33:862-875.
ABSTRACT | FULL TEXT  

Lipids and Atherosclerosis: Lessons Learned from Randomized Controlled Trials of Lipid Lowering and Other Relevant Studies
Kreisberg and Oberman
J. Clin. Endocrinol. Metab. 2002;87:423-437.
FULL TEXT  

Improving Lipid Evaluation and Management in Medicare Patients Hospitalized for Acute Myocardial Infarction
Malach et al.
Arch Intern Med 2001;161:839-844.
ABSTRACT | FULL TEXT  

Effects of Nonlipid Risk Factors on Atherosclerosis in Youth With a Favorable Lipoprotein Profile
McGill et al.
Circulation 2001;103:1546-1550.
ABSTRACT | FULL TEXT  

Choose a Diet That Is Low in Saturated Fat and Cholesterol and Moderate in Total Fat: Subtle Changes to a Familiar Message
Dixon and Ernst
J. Nutr. 2001;131:510S-526.
ABSTRACT | FULL TEXT  

A Reference Method Laboratory Network for Cholesterol: A Model for Standardization and Improvement of Clinical Laboratory Measurements
Myers et al.
Clin. Chem. 2000;46:1762-1772.
ABSTRACT | FULL TEXT  

Conquering Cardiovascular Disease: Progress and Promise
Lenfant
JAMA 1999;282:2068-2070.
FULL TEXT  

Tumor Necrosis Factor-alpha -mediated Protein Kinases in Regulation of Scavenger Receptor and Foam Cell Formation on Macrophage
Hsu and Twu
J. Biol. Chem. 2000;275:41035-41048.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.